Aptamer drug for detoxification of Staphylococcus aureus alpha-toxin
US9217134B1 · kind B1 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2014 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Aug 27, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/16
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Aptamers and methods of use thereof are presented for the treatment or diagnosis of Staphylococcus aureus infection. The aptamers binds to and capable of neutralization of Staphylococcus aureus alpha-toxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.